about
Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory controlReduced liver injury and cytokine release after transplantation of preconditioned intestines.Anti B-cell therapy against refractory thrombocytopenia in SLE and MCTD patients: long-term follow-up and review of the literature.IL-1 Receptor Antagonist Treatment Aggravates Staphylococcal Septic Arthritis and Sepsis in Mice.Circulating resistin levels are early and significantly increased in deceased brain dead organ donors, correlate with inflammatory cytokine response and remain unaffected by steroid treatment.Pathogenic Transdifferentiation of Th17 Cells Contribute to Perpetuation of Rheumatoid Arthritis during Anti-TNF Treatment.RAGE Deficiency Impairs Bacterial Clearance in Murine Staphylococcal Sepsis, but Has No Significant Impact on Staphylococcal Septic ArthritisInduction of arthritis by high mobility group box chromosomal protein 1 is independent of tumour necrosis factor signalling.Infliximab dose reduction sustains the clinical treatment effect in active HLAB27 positive ankylosing spondylitis: a two-year pilot study.Increased resistin in brain dead organ donors is associated with delayed graft function after kidney transplantation.The combination of a tumor necrosis factor inhibitor and antibiotic alleviates staphylococcal arthritis and sepsis in mice.Survivin in autoimmune diseases.CTLA4 Immunoglobulin but Not Anti-Tumor Necrosis Factor Therapy Promotes Staphylococcal Septic Arthritis in Mice.Antibiotic-killed Staphylococcus aureus induces destructive arthritis in mice.Intra-peritoneal sRAGE treatment induces alterations in cellular distribution of CD19(+), CD3 (+) and Mac-1 (+) cells in lymphoid organs and peritoneal cavity.Resistin in serum is associated with higher levels of IL-1Ra in post-menopausal women with rheumatoid arthritis.High Expression of STAT3 in Subcutaneous Adipose Tissue Associates with Cardiovascular Risk in Women with Rheumatoid Arthritis.Lack of Receptor for Advanced Glycation End products leads to less severe staphylococcal skin infection but more skin abscesses and prolonged wound healing.High mobility group box protein 1-A prognostic marker for structural joint damage in 10-year follow-up of patients with juvenile idiopathic arthritis.Donor pretreatment with FK506 reduces reperfusion injury and accelerates intestinal graft recovery in ratsSerum Levels of HMGB1 in Postmenopausal Patients with Rheumatoid Arthritis: Associations with Proinflammatory Cytokines, Acute-phase Reactants, and Clinical Disease CharacteristicsLow Serum IGF-1 in Boys with Recent Onset of Juvenile Idiopathic ArthritisExocrine pancreatic function is preserved in systemic sclerosisSoluble receptor for advanced glycation end products triggers a proinflammatory cytokine cascade via beta2 integrin Mac-1Synovial fluid expression of autoantibodies specific for RAGE relates to less erosive course of rheumatoid arthritisExtracellular cytochrome c, a mitochondrial apoptosis-related protein, induces arthritisOff-trial evaluation of the B cell-targeting treatment in the refractory cases of antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: long-term follow-up from a single centreSmoking Is Associated With Low Levels of Soluble PD-L1 in Rheumatoid ArthritisComplement Consumption in Systemic Lupus Erythematosus Leads to Decreased Opsonophagocytosis In VitroLow serum IGF1 is associated with hypertension and predicts early cardiovascular events in women with rheumatoid arthritisThe YIN and YANG of lipoproteins in developing and preventing infectious arthritis by Staphylococcus aureus
P50
Q24817102-D7CCCFE1-7062-44F9-8F09-C6EEAC25292CQ33393136-1B617A0B-18D2-442E-B903-399E9CE3CCB4Q33407247-D7157858-2D71-4532-9DDB-4958FAA7A67AQ35681138-DABFE577-26B8-4D04-954A-5125591A5252Q35785997-E3DC3DF1-54AF-4EAB-B6D6-FE7F7F6FE16BQ36167063-F0DBF0A8-9EC3-4B33-AFF9-78F7EF211071Q36209840-B0C04D57-0DF7-43F5-A0D2-8B1B18447E63Q36790415-E59D5C10-2B43-4165-B803-6B08DFAAFEE9Q37191464-36B1548E-0E86-44A1-9430-F8C3A2122A77Q37360572-021647D4-501C-4A33-B751-B84DF5103D64Q39262917-615F411A-7C4E-4EF7-BC53-174E47E4694AQ39341683-DD601C97-34C2-4211-BFE9-B8E79D2827F6Q41358884-32811C2B-40C0-4F41-A713-76B43F1E9679Q41706624-61B48CDD-F320-4D66-BD12-599FCC49A734Q43907504-B3E11714-A43E-4CD2-8FF8-51328730BF40Q46568292-3F9F869F-5D7C-423C-80DC-8BE89F9E30BBQ47408388-9FDDD5A5-73CC-4320-950C-A2D62CAA3907Q50062717-88EC25B0-ABA8-4DDC-9BDE-D16B6CA5FB25Q51378416-8B54D54E-6BD8-41F3-94EE-74D68A2B0A02Q56880501-D5B69069-AB91-4EFF-8F99-5FCAA27B9881Q57623472-0D2C0404-9642-46E2-84C0-3CC83F0B0E8EQ60932373-F225430D-F923-4361-9E12-8AFEF3C4871FQ64239358-D2D30DEE-C7C0-49CB-82E3-CA673F76642DQ79390919-F04AD5BA-3E35-4B2A-ADAB-629C3B337C51Q80479832-76EB8F77-CF45-4B8E-A028-F1C44EB10330Q80564208-695AB687-4B29-4EF6-AF9D-8F2F06F34EDCQ84599916-09F3754B-E24C-44E8-9262-53E756B377FBQ91116030-138F840A-1FEB-4B92-81E2-AD5E1CE6501CQ91260825-DC484BB8-6BCD-435B-BA54-DE74E4FF24AEQ92054246-F71EE5A7-0CD5-426D-9D93-C28F687E8730Q92936984-C9A8AFE3-E970-4CFB-9A63-72A409BA48BD
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Rille Pullerits
@ast
Rille Pullerits
@en
Rille Pullerits
@es
Rille Pullerits
@nl
type
label
Rille Pullerits
@ast
Rille Pullerits
@en
Rille Pullerits
@es
Rille Pullerits
@nl
prefLabel
Rille Pullerits
@ast
Rille Pullerits
@en
Rille Pullerits
@es
Rille Pullerits
@nl
P106
P1153
12799778100
P31
P496
0000-0002-5383-9817